Congenital Heart Disease Clinical Trial
— PReVaiLOfficial title:
Effect of Internet, Mobil Applications and SMS-based Encouragements to Intensive Exercise in Adolescents With Congenital Heart Disease
Verified date | September 2014 |
Source | Rigshospitalet, Denmark |
Contact | n/a |
Is FDA regulated | No |
Health authority | Denmark: Ethics Committee |
Study type | Interventional |
All over the world 0.8 % of all live children are born with a Congenital Heart Disease (CHD)
due to genetic end environmental causes. Advanced treatment and care has enhanced survival
substantially, and adults with CHD are a growing population requiring continuous monitoring
and care. Presently 25% of young adults acquire complicating Cardio Vascular Diseases (CVD)
in young adulthood amongst other co-morbidities.
It is known that adolescents with CHD are not as physical fit (PF) as their cardiac
capability allows, most likely for reasons concerning safety, ability plus inactive everyday
life. However, in 2006 The European Society of Cardiology states, that regular exercise at
recommended levels can be performed and should be encouraged in all patients with CHD.
Training programmes in hospitals have an effect on PF and Quality of Life (QoL) for the few,
as most adolescents' find it impossible to fit into everyday life.
It is the investigators hypothesis that an eHealth intervention, to facilitate intensive
exercise in the patients' neighbourhood environs, may improve physical fitness more
efficiently than standard lifestyle education.
The purpose of the study is to create evidence to recommend an efficient, fun and safe
cardiac rehabilitation programme to adolescents with CHD.
Primary outcome measure
Cardiopulmonary exercise capacity: Online V02 max bicycle test
Secondary outcome measure
Level of physical exercise: Actigraph and Questionnaire
Tertiary outcome measure
Quality of Life: PedsQl
Prevail is a national prospective, randomized clinical trial including 216 adolescents aged
13-16 years, who have had cardiac surgery in childhood owing to complex CHD. The patients
included are all recommended to be as physical active as their healthy peers and pursue the
principle guideline from The National Board of Health: "All children and young people must
be physically active for at least 60 minutes a day, preferably longer". Patients with mental
retardation and FEV1 at baseline < 80% of predicted are excluded.
The risk of participating in the purposed trial is not regarded as higher than everyday
daily living.
Results will be interpreted according to affiliation to health related fitness clusters.
Status | Completed |
Enrollment | 158 |
Est. completion date | May 2014 |
Est. primary completion date | May 2014 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 13 Years to 16 Years |
Eligibility |
Inclusion Criteria: - Congenital heart disease with allowance for unrestricted exercise - Diagnosis: Q20.0 Truncus arteriosus communis, Q20.1 Transpositio vasorum incompleta, Q20.3 Transpositio vasorum completa, Q20.5 Inversio ventriculorum cordis, Q21.2 Defectus septi atrioventriculorum cordis, Q21.3 Tetralogia Steno-Fallot, Q22.4 Tricusspidalatresia , Q22.5 Anomalia Ebstein, Q23.2 Mitralatresia, Double outlet right ventricle, Q23.3 Hypoplasia ventriculi sinistri cordis syndrome, Q23.3 Hypoplasia ventriculi dextrii cordis syndrome, Q24.4 Stenosis subaortae congenita, Q25.1 Coarctatio aortae, Q25.1 Coarctatio Aortae, Double inlet left ventricle, Q25.3 Stenosis aortae supravalvularis, Q25.5 Pulmonalatresia. - Successful Total Cavo Pulmonal Connex (TCPC procedure) - 13- 16 years of age Exclusion Criteria: - Mental retardation - Untreated asthma - Syndromes related to CHD |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Health Services Research
Country | Name | City | State |
---|---|---|---|
Denmark | University Hospital Copenhagen | Copenhagen | RegionH |
Lead Sponsor | Collaborator |
---|---|
Rigshospitalet, Denmark |
Denmark,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Cardiopulmonary exercise capacity | Online V02 max bicycle test | 12 months | No |
Secondary | Level of physical exercise | Actigraph and Questionnaire | 12 months | No |
Secondary | Quality of Life | PedsQl | 12 months | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05654272 -
Development of CIRC Technologies
|
||
Recruiting |
NCT04992793 -
Paediatric Brain Injury Following Cardiac Interventions
|
||
Recruiting |
NCT05213598 -
Fontan Associated Liver Disease and the Evaluation of Biomarkers for Disease Severity Assessment
|
||
Completed |
NCT04136379 -
Comparison of Home and Standard Clinic Monitoring of INR in Patients With CHD
|
||
Completed |
NCT04814888 -
3D Airway Model for Pediatric Patients
|
||
Recruiting |
NCT04920643 -
High-exchange ULTrafiltration to Enhance Recovery After Pediatric Cardiac Surgery
|
N/A | |
Completed |
NCT05934578 -
Lymphatic Function in Patients With Fontan Circulation: Effect of Physical Training
|
N/A | |
Recruiting |
NCT06041685 -
Effect of Local Warming for Arterial Catheterization in Pediatric Anesthesia
|
N/A | |
Recruiting |
NCT05902013 -
Video Laryngoscopy Versus Direct Laryngoscopy for Nasotracheal Intubation
|
N/A | |
Not yet recruiting |
NCT05687292 -
Application of a Clinical Decision Support System to Reduce Mechanical Ventilation Duration After Cardiac Surgery
|
||
Not yet recruiting |
NCT05524324 -
Cardiac Resynchronization Therapy in Adult Congenital Heart Disease With Systemic Right Ventricle: RIGHT-CRT
|
N/A | |
Completed |
NCT02746029 -
Cardiac Murmurs in Children: Predictive Value of Cardiac Markers
|
||
Completed |
NCT02537392 -
Multi-micronutrient Supplementation During Peri-conception and Congenital Heart Disease
|
N/A | |
Completed |
NCT03119090 -
Fontan Imaging Biomarkers (FIB) Study
|
||
Recruiting |
NCT02258724 -
Swiss National Registry of Grown up Congenital Heart Disease Patients
|
||
Terminated |
NCT02046135 -
Sodium Bicarbonate to Prevent Acute Kidney Injury in Children Undergoing Cardiac Surgery
|
Phase 2 | |
Completed |
NCT01966237 -
Milrinone Pharmacokinetics and Acute Kidney Injury
|
||
Recruiting |
NCT01184404 -
Bosentan Improves Clinical Outcome of Adults With Congenital Heart Disease or Mitral Valve Lesions Who Undergo CArdiac Surgery
|
N/A | |
Completed |
NCT01548950 -
Drug Therapy and Surgery in Congenital Heart Disease With Pulmonary Hypertension
|
N/A | |
Completed |
NCT01821287 -
Nutritional Failure in Infants With Single Ventricle Congenital Heart Disease
|
N/A |